Literature DB >> 8030263

Two novel multigene families, 530 and 300, in the terminal variable regions of African swine fever virus genome.

T Yozawa1, G F Kutish, C L Afonso, Z Lu, D L Rock.   

Abstract

Here, we describe two novel multigene families (MGF) present in the terminal variable regions of the African swine fever virus (ASFV) genome. MGF530 includes at least six related ORFs (averaging 530 amino acids) containing four well-conserved domains and amino acid identities ranging from 24 to 55%. MGF300 is composed of three ORFs (averaging 300 amino acids) containing three highly conserved domains and amino acid identities ranging from 25 to 46%. Amino terminal regions of predicted MGF530 and 300 proteins share significant similarity with each other and with the comparable regions of previously characterized MGF360 ORFs. Members of both MGF530 and 300 are transcribed in ASFV-infected porcine macrophages. These results indicate that the composition and organization of MGF in the terminal variable region of the ASFV genome are more complex than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030263     DOI: 10.1006/viro.1994.1426

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  African Swine Fever Virus Georgia Isolate Harboring Deletions of MGF360 and MGF505 Genes Is Attenuated in Swine and Confers Protection against Challenge with Virulent Parental Virus.

Authors:  Vivian O'Donnell; Lauren G Holinka; Douglas P Gladue; Brenton Sanford; Peter W Krug; Xiqiang Lu; Jonathan Arzt; Bo Reese; Consuelo Carrillo; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  African swine fever virus multigene family 360 and 530 genes are novel macrophage host range determinants.

Authors:  L Zsak; Z Lu; T G Burrage; J G Neilan; G F Kutish; D M Moore; D L Rock
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Novel swine virulence determinant in the left variable region of the African swine fever virus genome.

Authors:  J G Neilan; L Zsak; Z Lu; G F Kutish; C L Afonso; D L Rock
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Sequence and organization of the left multigene family 110 region of the Vero-adapted L60V strain of African swine fever virus.

Authors:  S Pires; G Ribeiro; J V Costa
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  A comparative analysis on the synonymous codon usage pattern in viral functional genes and their translational initiation region of ASFV.

Authors:  Jian-Hua Zhou; Zong-Liang Gao; Dong-Jie Sun; Yao-Zhong Ding; Jie Zhang; Laszlo Stipkovits; Susan Szathmary; Zygmunt Pejsak; Yong-Sheng Liu
Journal:  Virus Genes       Date:  2012-11-16       Impact factor: 2.332

6.  Characterization of baculovirus repeated open reading frames (bro) in Bombyx mori nucleopolyhedrovirus.

Authors:  W Kang; M Suzuki; E Zemskov; K Okano; S Maeda
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  A nonessential African swine fever virus gene UK is a significant virulence determinant in domestic swine.

Authors:  L Zsak; E Caler; Z Lu; G F Kutish; J G Neilan; D L Rock
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  The subcellular distribution of multigene family 110 proteins of African swine fever virus is determined by differences in C-terminal KDEL endoplasmic reticulum retention motifs.

Authors:  Christopher Netherton; Isabelle Rouiller; Thomas Wileman
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  African swine fever virus multigene family 360 genes affect virus replication and generalization of infection in Ornithodoros porcinus ticks.

Authors:  T G Burrage; Z Lu; J G Neilan; D L Rock; L Zsak
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  African swine fever virus multigene family 360 and 530 genes affect host interferon response.

Authors:  C L Afonso; M E Piccone; K M Zaffuto; J Neilan; G F Kutish; Z Lu; C A Balinsky; T R Gibb; T J Bean; L Zsak; D L Rock
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.